All Stories

  1. Posterior versus anterior circulation infarct location and outcomes after breakthrough ischemic stroke in orally anticoagulated patients for atrial fibrillation: An ASPERA-R inverse probability–weighted analysis
  2. Venous Thrombotic and Thromboembolic Considerations in Stroke: An Expert Meeting Report on Future Directions for Clinical Trials
  3. Contemporary achievement of guideline recommendations for blood pressure management after stroke in the CONVINCE trial
  4. Early versus late starting of direct oral anticoagulants after breakthrough ischemic stroke: A target trial analysis from the ASPERA-R study
  5. Acute non-alcoholic caffeinated beverage consumption as a trigger for cryptogenic ischemic stroke in the young: findings from the SECRETO study
  6. Competing Stroke Etiologies and Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants in Patients With Atrial Fibrillation
  7. Association Between Physical Activity and Cryptogenic Ischemic Stroke in Young Adults: A Case–Control Study
  8. Continuation vs Switching Direct Oral Anticoagulant Therapy After Breakthrough Stroke
  9. Sex Differences in Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants for Atrial Fibrillation: An ASPERA‐R Inverse Probability Weighted Analysis
  10. Biomarkers for advancing diagnosis and prognosis in stroke
  11. Dissecting Aneurysm in Cervical Artery Dissection: Insights From the STOP-CAD Study
  12. Recurrent Cervical Artery Dissection Prevalence and Predictors: A Secondary Analysis of the STOP-CAD Study
  13. Validation of the SMART-REACH model after stroke and the effect of colchicine by atherosclerotic cardiovascular disease risk category: a secondary analysis of the CONVINCE randomised clinical trial
  14. Cardiac Organ Damage in Young Adults with Cryptogenic Ischaemic Stroke: The SECRETO Study
  15. Preceding Infections and Coagulation Biomarkers in Early-Onset Cryptogenic Ischemic Stroke
  16. Thrombophilia Screening in Young Patients With Cryptogenic Ischemic Stroke
  17. Family history of stroke and cardiovascular diseases in early-onset cryptogenic ischaemic stroke
  18. Cervical Artery Dissection Diagnosed Following Chiropractic Cervical Manipulation
  19. Anti-beta2-glycoprotein I IgG antibodies are associated with early-onset cryptogenic ischemic stroke
  20. Stroke Action Plan for Europe 2018–2030 (SAP-E): mid-term review and update
  21. Effect of colchicine for secondary prevention according to stroke subtype: A secondary analysis of the CONVINCE randomized trial
  22. Fibromuscular Dysplasia and Spontaneous Cervical Artery Dissection
  23. Outcomes After Reversible Cerebral Vasoconstriction Syndrome With Convexity Subarachnoid Hemorrhage
  24. Unrecognized Myocardial Fibrosis Detected by Contrast-Enhanced Cardiovascular MRI in Patients With Ischemic Stroke
  25. Anti-beta2-glycoprotein I IgG antibodies are associated with early-onset cryptogenic ischemic stroke
  26. Burden of Modifiable Risk Factors in Young-Onset Cryptogenic Ischemic Stroke by High-Risk Patent Foramen Ovale
  27. Factors Associated With Stroke Recurrence After Initial Diagnosis of Cervical Artery Dissection
  28. Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019
  29. Association Between Self-Perceived Stress and Cryptogenic Ischemic Stroke in Young Adults
  30. Association of Smoking and Young Cryptogenic Ischemic Stroke
  31. Anticoagulation in Atrial Fibrillation With Valvular Heart Disease
  32. Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  33. Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trial
  34. Association between heavy alcohol consumption and cryptogenic ischaemic stroke in young adults: a case–control study
  35. Association of Left Atrial Stiffness With Risk of Cryptogenic Ischemic Stroke in Young Adults
  36. Antithrombotic Treatment for Stroke Prevention in Cervical Artery Dissection: The STOP-CAD Study
  37. Stroke frequency, associated factors, and clinical features in primary systemic vasculitis: a multicentric observational study
  38. Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  39. Editorial: Pushing the frontiers of stroke care and research - where are we heading?
  40. Stroke and Recent Myocardial Infarction, Reduced Left Ventricular Ejection Fraction, Left Ventricular Thrombus, and Wall Motion Abnormalities
  41. Deep Learning-Based Extraction of Biomarkers for the Prediction of the Functional Outcome of Ischemic Stroke Patients
  42. Neglect scoring modifications in the National Institutes of Health Stroke Scale improve right hemisphere stroke lesion volume prediction
  43. Sensitivity and Accuracy of Doppler Ultrasound compared to CT Angiography for the Diagnosis of Carotid Webs: Systematic Review
  44. Diagnosis of atrial fibrillation in young patients with ischemic stroke: A systematic review and meta-analysis
  45. Potential and limitations of computed tomography images as predictors of the outcome of ischemic stroke events: a review
  46. Ultrasonographic Vasospasm and Outcome of Posterior Reversible Encephalopathy and Cerebral Vasoconstriction Syndromes
  47. Update on Biomarkers Associated with Large-Artery Atherosclerosis Stroke
  48. Update on Biomarkers Associated with Large Artery Atherosclerosis Stroke
  49. Gout Flare and Cardiovascular Events
  50. Follow-Up by Transcranial Doppler After Rupture of a Giant Intracranial Aneurysm
  51. Clinical presentation and neural correlates of stroke‐associated spatial delusions
  52. Leaving no stone unturned: the search for stroke associated with atrial fibrillation
  53. Time perception changes in stroke patients: A systematic literature review
  54. Organizational Update: World Stroke Conference 2021
  55. Obesity and the Risk of Cryptogenic Ischemic Stroke in Young Adults
  56. How Can Biobanks Help You in Your Research Projects?
  57. Incorporating Quality Improvement Projects Into Stroke Care and Research
  58. EXPRESS: European Stroke Organisation (ESO) – European Society for Minimally Invasive Neurological Therapy (ESMINT) expedited recommendation on indication for intravenous thrombolysis before mechanical thrombectomy in patients with acute ischaemic stro...
  59. European Stroke Organisation (ESO)–European Society for Minimally Invasive Neurological Therapy (ESMINT) expedited recommendation on indication for intravenous thrombolysis before mechanical thrombectomy in patients with acute ischemic stroke and anter...
  60. Acute Myocardial Infarction after Intravenous Thrombolysis for Acute Ischemic Stroke: Case Series and Systematic Review
  61. From Forensics to Clinical Research: Expanding the Variant Calling Pipeline for the Precision ID mtDNA Whole Genome Panel
  62. Mapping delusions of space onto a structural disconnectome that decouples familiarity and place networks
  63. Uncertainties and Controversies in the Management of Ischemic Stroke and Transient Ischemic Attack Patients With Patent Foramen Ovale
  64. Cerebrovascular Complications of Anemia
  65. The dawn of precision medicine in stroke
  66. Risk of intracranial haemorrhage and ischaemic stroke after convexity subarachnoid haemorrhage in cerebral amyloid angiopathy: international individual patient data pooled analysis
  67. Colchicine for prevention of vascular inflammation in Non-CardioEmbolic stroke (CONVINCE) – study protocol for a randomised controlled trial
  68. Mean Platelet Volume is a Prognostic Marker in Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis
  69. Update on Biomarkers Associated to Cardioembolic Stroke: A Narrative Review
  70. Undergraduate neurology teaching: Comparison of an inpatient versus outpatient clinical setting
  71. Unravelling the Neural Basis of Spatial Delusions After Stroke
  72. European Stroke Organisation (ESO) guidelines on management of transient ischaemic attack
  73. European Stroke Organisation expedited recommendation for the use of short-term dual antiplatelet therapy early after minor stroke and high-risk TIA
  74. European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke
  75. Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Portugal
  76. An image is not always worth a thousand words: an image mimic of transient global amnesia
  77. Cardiovascular magnetic resonance imaging and its role in the investigation of stroke: an update
  78. Neurological complications of cardiomyopathies
  79. Precision Medicine in Stroke
  80. Undergraduate neurology teaching: comparison of an inpatient versus outpatient clinical setting.
  81. Author response: Undetermined stroke genesis and hidden cardiomyopathies determined by cardiac magnetic resonance
  82. Association between migraine and cryptogenic ischemic stroke in young adults
  83. Transient Ischemic Attack
  84. Value of Treatment by Comprehensive Stroke Services for the reduction of critical gaps in acute stroke care in Europe
  85. Undetermined stroke genesis and hidden cardiomyopathies determined by cardiac magnetic resonance
  86. Intravenous Thrombolysis for Acute Ischemic Stroke After Recent Myocardial Infarction
  87. Neurological Complications of Infective Endocarditis
  88. Chronic headache with vasospasm treated with nimodipine
  89. Neurological Complications of Cardiac Tumors
  90. Etiologic Evaluation of Ischemic Stroke in Young Adults: A Comparative Study between Two European Centers
  91. Women Who Have Ischemic Strokes Have a Higher Burden of Left Atrial Fibrosis Than Men
  92. Quantitative EEG and functional outcome following acute ischemic stroke
  93. Memory impairment due to bilateral fornix infarction: Characterisation and follow-up
  94. Patent foramen ovale and stroke
  95. Early EEG predicts poststroke epilepsy
  96. Patients With Undetermined Stroke Have Increased Atrial Fibrosis
  97. European Academy of Neurology and European Stroke Organization consensus statement and practical guidance for pre-hospital management of stroke
  98. Voluntary control of a plegic limb during yawning
  99. Using Machine Learning to Improve the Prediction of Functional Outcome in Ischemic Stroke Patients
  100. Bilateral parotid gland hemorrhage after intravenous thrombolysis for stroke treatment
  101. Seizures, electroencephalographic abnormalities, and outcome of ischemic stroke patients
  102. Post-stroke seizures are clinically underestimated
  103. Epilepsia partialis continua after an anterior circulation ischaemic stroke
  104. Epileptic manifestations in stroke patients treated with intravenous alteplase
  105. Searching for Explanations for Cryptogenic Stroke in the Young: Revealing the Triggers, Causes, and Outcome (SECRETO): Rationale and design
  106. The Changing Landscape for Stroke Prevention in AF
  107. Increase in the Admission of Stroke Mimics after Change in Emergency Shifts
  108. An unsuspected cause of hypnic-like headache
  109. Laterality of Pneumonia in Acute Stroke
  110. Loss of object ownership feeling following a left hemisphere infarct
  111. One-Year Risk of Stroke after Transient Ischemic Attack or Minor Stroke
  112. Language improvement one week after thrombolysis in acute stroke
  113. Recurrent cerebral ischaemic events in the setting of paroxysmal nocturnal haemoglobinuria
  114. Subarachnoid Haemorrhage and Sports
  115. Brain Magnetic Resonance with Negative Diffusion-Weighted Imaging: Does It Preclude Acute Stroke Diagnosis?
  116. Axial myoclonus after ischemic stroke
  117. Short-term outcome of patients with possible transient ischemic attacks: a prospective study
  118. B-Type Natriuretic Peptides Help in Cardioembolic Stroke Diagnosis: Pooled Data Meta-Analysis
  119. Cryptogenic stroke
  120. Ischemic Stroke
  121. Stroke: an update
  122. Infective endocarditis
  123. Nontraumatic Convexity Subarachnoid Hemorrhage: Different Etiologies and Outcomes
  124. N-Terminal Pro-Brain Natriuretic Peptide Shows Diagnostic Accuracy for Detecting Atrial Fibrillation in Cryptogenic Stroke Patients
  125. Cotard delusion after stroke
  126. Time course of NT-proBNP levels after acute ischemic stroke
  127. Drug Abuse and Stroke
  128. Does Anticoagulation Promote Mural Hematoma Growth or Delayed Occlusion in Spontaneous Cervical Artery Dissections
  129. Snoring and Severity of Symptomatic and Asymptomatic Carotid Stenosis: A Population-Based Study
  130. Why did we perform a lumbar puncture in a young patient with ischemic stroke?
  131. Improvement of sleep architecture in the follow up of a patient with bilateral paramedian thalamic stroke
  132. Treatment with rtPA of stroke associated with intravenous immunoglobulins perfusion
  133. N-Terminal Probrain Natriuretic Peptide as a Biomarker of Cardioembolic Stroke
  134. Diagnostic difficulties in the classification of transient neurological attacks
  135. Neck Hematoma after Intravenous Thrombolysis for Stroke Treatment
  136. Influence of climatic factors in the incidence of multiple sclerosis relapses in a Portuguese population
  137. Reversible bilateral sensorineural hearing loss in a woman with cerebral venous thrombosis
  138. Sneeze as a precipitating factor of cerebral venous thrombosis